Cotemar Growth and Success

There are many people who are excited about the changes that are taking place in the oil industry Mexico. With that being said, few companies are in as good of a position as Cotemar right now. This is a company that is truly working to take things to the next level in their industry. Not only does the company have one of the leading investing plans in the world for oil, but they are also helping the environment in any way that they can. If you want to start investing for the future, Cotemar is a great company to look at. Many people today are ready to see what this company can do for Mexico’s economy.

 

Cotemar

 

Over the years, Mexico has become a leading power in the oil industry. As the OPEC continue to cut production, Cotemar is a company that is looking to expand their reach in Mexico. Many people do not know that the country has a huge amount of oil reserves that are there for the taking. When the company first started, Cotemar concentrated on how to scale the business up with technology and with the proper investments. In this case, they are ahead of the game and are ready to start investing in many ways. There are many people who are excited about the changes that are going to take place in this area. If you are ready to see what you can do for the growth of your business, Cotemar is the company to look at.

 

Capital in the Oil Industry

 

One of the reasons that the oil industry is so hard to break into is the high capital needs on the front end. Many people do not realize that oil companies must front a lot of capital just to get started in this area. If you want to invest for the future, now is a great time to do that. There are many people who are excited about the changes that Cotemar is doing with its new technology. Not only is the technology going to make a difference in the lives of others, but it is also going to be there for others to follow. Cotemar is in a great financial position because they can operate with low costs and little debt. Few companies in this industry can say the same thing, and Cotemar is getting ready to invest as much money as possible for the future.

Learn more:

http://www.bnamericas.com/company-profile/es/cotemar-sa-de-cv-cotemar

http://www.elmanana.com/tags/cotemar-32181/

Could This be the Awaited Breakthrough for Treating Multiple Sclerosis?

The Medicine profession is considered technical. Neurologists such as Dr. Shiva Gopal Vasishita, for instance, are specifically trained in the diagnosis and treatment of nervous system disorders including ailments of the brain, spinal cord, nerves, and muscles. They are subjected to a rigorous education system meant to build their capacity of the complexities that await them in neurology.

Dr. Shiva Gopal Vasishita happens to be one of the practicing neurologists we have today. He graduated from Government Medical College in 1979 and has been practicing both neurology and psychiatry for 40years now in Voorhees, New Jersey. In his line of work, Dr. Shiva plays a vital role in explaining the mechanisms of a traumatic brain injury, the results of clinical examination and the significance of diagnostic test results.

On 1st February 2017, the National Institute of Health disclosed that evidence from recent trials suggested that high-dose immunosuppressive therapy then a transplant of a person’s blood- forming stem cells had the ability to induce sustained remission of relapsing-remitting multiple sclerosis. 69 percent of the trial participants survived without experiencing progression of disability, relapsing of MS syndrome or new brain lesions five years later after receiving high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT). The participants did not need any MS medication after receiving HDIT/HCT.

The trial that was sponsored by the National Institute of Allergy and Infectious Diseases (NIAD) published the final five-year results in Neurology- the medical journal of the American Academy of Neurology on 1st February.

The possibility of a one-time HDIT/HCT treatment being substantially more effective than long-term treatment with medications for Multiple Sclerosis is great news for neurologists such as Dr. Shiva who are committed to getting breakthroughs in solving brain diseases.